Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,081 | 64,593 | 115,684 | 109,661 | 127,677 |
| Marketable Securities | 215,765 | 234,667 | 137,918 | 184,921 | 205,611 |
| Receivables | 14,867 | 14,541 | 13,831 | 8,117 | 6,224 |
| Inventories | 8,624 | 7,762 | 6,178 | 5,487 | 2,917 |
| TOTAL | $308,268 | $329,201 | $283,878 | $317,838 | $354,236 |
| Non-Current Assets | |||||
| PPE Net | 1,341 | 1,545 | 1,773 | 2,001 | 2,197 |
| Intangibles | 7,028 | 7,242 | 7,456 | 7,669 | 7,883 |
| Other Non-Current Assets | 16,108 | 16,211 | 16,836 | 18,170 | 18,165 |
| TOTAL | $24,477 | $24,998 | $26,065 | $27,840 | $28,245 |
| Total Assets | $332,745 | $354,199 | $309,943 | $345,678 | $382,481 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,885 | 3,839 | 8,383 | 13,347 | 4,797 |
| Accrued Expenses | 48,262 | 44,271 | 35,708 | 30,549 | 32,894 |
| TOTAL | $55,203 | $50,144 | $46,103 | $46,029 | $39,809 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,286 | 1,286 | 1,286 | 1,428 | 1,434 |
| Other Non-Current Liabilities | 1,640 | 1,882 | 2,208 | 2,366 | 2,600 |
| TOTAL | $107,783 | $106,581 | $81,555 | $79,886 | $78,410 |
| Total Liabilities | $162,986 | $156,725 | $127,658 | $125,915 | $118,219 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,141 | 59,096 | 56,902 | 56,855 | 56,748 |
| Common Shares | 59 | 59 | 57 | 56 | 56 |
| Retained earnings | -894,736 | -853,103 | -808,940 | -762,237 | -710,058 |
| Other shareholders' equity | 134 | -113 | -14 | -6 | -92 |
| TOTAL | $169,759 | $197,474 | $182,285 | $219,763 | $264,262 |
| Total Liabilities And Equity | $332,745 | $354,199 | $309,943 | $345,678 | $382,481 |